Nivolumab and its use in the second-line treatment of metastatic urothelial cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nivolumab and its use in the second-line treatment of metastatic urothelial cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences